Lexaria Announces Exercises of Existing Warrants

Tickers: XCNQ:LXX, XOTC:LXRP, PINX:LXRPTags: None Kelowna, British Columbia / TheNewswire / January 17, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces various option and warrant transactions. Lexaria announces it has received US$ 349,223.44 from the exercise of warrants and options previously granted. The options…

Lexaria Announces Exercises of Existing Warrants

Tickers: XCNQ:LXX, XOTC:LXRPTags: None Kelowna, British Columbia / TheNewswire / December 22, 2017 – Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces various option and warrant transactions. Lexaria announces it has received US$ 95,857.20 from the exercise of a stock warrants and a compensation option certificate…

Lexaria Bioscience Announces New Research Including Cannabinoid Topical Creams and Nicotine Edibles

Tickers: XCNQ:LXX, XOTC:LXRPTags: None Kelowna, British Columbia / TheNewswire / December 15, 2017 – Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces a new topical skin cream research and development ("R&D") program; R&D into nicotine edibles; and updates existing R&D programs.…

Lexaria Bioscience Receives U.S. Patent Award for its DehydraTECH(tm) Delivery of THC, NSAIDs, Nicotine and Vitamins

Tickers: XCNQ:LXX, XOTC:LXRPTags: None Kelowna, British Columbia / TheNewswire / December 13, 2017 – Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") a drug delivery platform innovator, announces the United States Patent and Trademark Office ("USPTO") has granted patent number 9,839,612 B2 for the use of DehydraTECHTM…

Lexaria Announces No Material Developments

Tickers: XCNQ:LXX, XOTC:LXRPTags: Medicinal Marijuana Kelowna, British Columbia / TheNewswire / December 8, 2017 – Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces, at the request of the Investment Industry Regulatory Organization of Canada (IIROC), it is not aware of any undisclosed material change to the…

Lexaria Announces Option and Warrant Transactions

Tickers: XCNQ:LXX, XOTC:LXRPTags: Medicinal Marijuana Kelowna, British Columbia / TheNewswire / December 1, 2017 – Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces various stock, option and warrant transactions. Lexaria announces it has received US$ 6,733.02 from the exercise of a compensation option certificate previously granted.…

Lexaria Announces Upcoming Investment Event and Warrant Exercise

Tickers: XCNQ:LXX, XOTC:LXRPTags: Medicinal Marijuana Kelowna, British Columbia / TheNewswire / November 27, 2017 – Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces it is attending and delivering a presentation at the upcoming 10th annual LD Micro Main Event on December 5-7 located in Los Angeles.…

Lexaria Bioscience Files Innovative New Patent Application

Tickers: XCNQ:LXX, XOTC:LXRPTags: Medicinal Marijuana Kelowna, British Columbia / TheNewswire / November 9, 2017 – Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") a drug delivery platform innovator, announces it has filed a new patent application with the US Patent and Trademark Office ("USPTO") utilizing the Lexaria…

Lexaria Bioscience Acquires 100% Ownership of Poviva Tea LLC

Tickers: XCNQ:LXX, XOTC:LXRPTags: Medicinal Marijuana Kelowna, British Columbia / TheNewswire / November 2, 2017 – Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") a drug delivery platform innovator, announces it has acquired 100% ownership interest in its majority owned subsidiary Poviva Tea, LLC. Lexaria previously owned 51%…

Lexaria Bioscience Receives Groundbreaking U.S. Patent Allowance for its DehydraTECHTM Delivery of THC, NSAIDs, Nicotine and Vitamins.

Tickers: XCNQ:LXX, XOTC:LXRPTags: Medicinal Marijuana Kelowna, British Columbia / TheNewswire / October 31, 2017 – Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") a drug delivery platform innovator, announces it has received a new Notice of Allowance from the United States Patent and Trademark Office ("USPTO") for…